These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Participation of transient receptor potential vanilloid 1 in the analgesic effect of duloxetine for paclitaxel induced peripheral neuropathic pain. Wang J; Zhou F; Zhang S; Mao M; Feng S; Wang X Neurosci Lett; 2022 Mar; 773():136512. PubMed ID: 35149198 [TBL] [Abstract][Full Text] [Related]
10. TRPA1 involved in miR-141-5p-alleviated neuropathic pain induced by oxaliplatin. Zhang H; Chen H Neuroreport; 2021 Feb; 32(3):284-290. PubMed ID: 33534373 [TBL] [Abstract][Full Text] [Related]
11. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences. Noya-Riobó MV; Miguel CÁ; Soriano DB; Brumovsky PR; Villar MJ; Coronel MF Exp Neurol; 2023 Jan; 359():114232. PubMed ID: 36179876 [TBL] [Abstract][Full Text] [Related]
12. Reduction of SIRT1-Mediated Epigenetic Upregulation of Nav1.7 Contributes to Oxaliplatin-Induced Neuropathic Pain. Xu LJ; Wang J; Li YD; Shen KF; He XH; Wu W; Liu CC Pain Physician; 2023 May; 26(3):E213-E222. PubMed ID: 37192244 [TBL] [Abstract][Full Text] [Related]
13. The anticancer antibiotic mithramycin-A inhibits TRPV1 expression in dorsal root ganglion neurons. Zavala K; Lee J; Chong J; Sharma M; Eilers H; Schumacher MA Neurosci Lett; 2014 Aug; 578():211-6. PubMed ID: 24468003 [TBL] [Abstract][Full Text] [Related]
14. Role of pattern recognition receptors in chemotherapy-induced neuropathic pain. Araldi D; Khomula EV; Bonet IJM; Bogen O; Green PG; Levine JD Brain; 2024 Mar; 147(3):1025-1042. PubMed ID: 37787114 [TBL] [Abstract][Full Text] [Related]
15. Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity. Illias AM; Gist AC; Zhang H; Kosturakis AK; Dougherty PM Pain; 2018 Jul; 159(7):1308-1316. PubMed ID: 29554018 [TBL] [Abstract][Full Text] [Related]
16. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy. Resta F; Micheli L; Laurino A; Spinelli V; Mello T; Sartiani L; Di Cesare Mannelli L; Cerbai E; Ghelardini C; Romanelli MN; Mannaioni G; Masi A Neuropharmacology; 2018 Mar; 131():403-413. PubMed ID: 29339292 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of ERK phosphorylation in rat dorsal root ganglion neurons contributes to oxaliplatin-induced chronic neuropathic pain. Maruta T; Nemoto T; Hidaka K; Koshida T; Shirasaka T; Yanagita T; Takeya R; Tsuneyoshi I PLoS One; 2019; 14(11):e0225586. PubMed ID: 31765435 [TBL] [Abstract][Full Text] [Related]
19. MiR-30b-5p attenuates oxaliplatin-induced peripheral neuropathic pain through the voltage-gated sodium channel Na Li L; Shao J; Wang J; Liu Y; Zhang Y; Zhang M; Zhang J; Ren X; Su S; Li Y; Cao J; Zang W Neuropharmacology; 2019 Jul; 153():111-120. PubMed ID: 31054938 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma agonist ELB00824 suppresses oxaliplatin-induced pain, neuronal hypersensitivity, and oxidative stress. Zhang M; Hu M; Alles SRA; Montera MA; Adams I; Santi MD; Inoue K; Tu NH; Westlund KN; Ye Y Neuropharmacology; 2022 Nov; 218():109233. PubMed ID: 36007855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]